Xifaxan
Product Images NDC 68258-1107

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Xifaxan (NDC 68258-1107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 68258-1107-xx (Ndc 68258 1107 Xx Salix)

XIFAXAN 200 mg film-coated tablets label showing the product name, strength, and NDC 68258-1107-XX. The label includes directions for use, bulk source data, warnings to keep out of children's reach, storage conditions, lot sample information, and the dispensing company Dispensing Solutions, Inc. Manufacturer details and a barcode are also present.*

FDA Label Image

Xifaxan Structural Formula (Xifaxan 1)

Chemical structure of the active ingredient for XIFAXAN by Dispensing Solutions, Inc. The structure depicts a complex molecular formula with multiple hydroxyl, methyl, and other functional groups characteristic of the compound.*

FDA Label Image

Kaplan-meier Event-free Curves Graph (Xifaxan 2)

A Kaplan-Meier survival curve chart showing the proportion of patients without breakthrough hepatic encephalopathy (HE) over days post-randomization. Two curves are displayed: one labeled XIFAXAN and the other Placebo, with XIFAXAN having consistently higher proportions over time. The chart includes a hazard ratio (0.421) with 95% confidence interval (0.276 to 0.641) and a log-rank p-value of less than 0.0001.*

FDA Label Image

Kaplan-meier Event-free Curves_pivotalhestudy (Xifaxan 3)

A Kaplan-Meier survival curve comparing the proportion of patients without HE-related hospitalization over days post-randomization between XIFAXAN and placebo groups. The graph shows XIFAXAN has a higher proportion of patients without hospitalization over time. The inset box displays a hazard ratio of 0.500 with 95% CI (0.287, 0.873) and a log-rank p-value of 0.0129, indicating statistical significance.*

FDA Label Image

Salix-logo (Xifaxan 4)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.